Cited by 348Pluripotent Stem Cells ResearchDevelopmental Biology and Gene RegulationNeurogenesis and neuroplasticity mechanisms

Tgfβ Signal Inhibition Cooperates in the Induction of iPSCs and Replaces Sox2 and cMyc

Open access
Maherali, Nimet, Hochedlinger, Konrad·2009·Current Biology

Abstract

Ectopic expression of Oct4, Sox2, cMyc, and Klf4 confers a pluripotent state upon several differentiated cell types, generating induced pluripotent stem cells (iPSCs) [1-8]. iPSC derivation is highly inefficient, and the underlying mechanisms are largely unknown. This low efficiency suggests the existence of additional cooperative factors whose identification is critical for understanding reprogramming. In addition, the therapeutic use of iPSCs relies on the development of efficient nongenetic means of factor delivery, and although a handful of replacement molecules have been identified, their use yields a further reduction to the already low reprogramming efficiency [9-11]. Thus, the identification of compounds that enhance rather than solely replace the function of the reprogramming factors will be of great use. Here, we demonstrate that inhibition of Tgfbbeta signaling cooperates in the reprogramming of murine fibroblasts by enabling faster, more efficient induction of iPSCs, whereas activation of Tgfbeta signaling blocks reprogramming. In addition to exhibiting a strong cooperative effect, the Tgfbeta receptor inhibitor bypasses the requirement for exogenous cMyc or Sox2, highlighting its dual role as a cooperative and replacement factor. The identification of a highly characterized pathway operating in iPSC induction will open new avenues for mechanistic dissection of the reprogramming process.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cub.2009.08.025

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • E-616452 (RepSox) is a TGF-β inhibitor that has been used to replace SOX2 during epigenetic reprogramming.

    “E-616452, also known as RepSox, is a TGF-β inhibitor that has been used in experiments to replace SOX2 during epigenetic reprogramming [68, 69].”

    From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [69]

    Experimental Procedures (Cell culture and iPSC induction; page unavailable) identifies the inhibitor used as Calbiochem/EMD 616452. Results and Discussion (page unavailable) reports that the inhibitor enabled Sox2 replacement during iPSC reprogramming. Our copy does not identify 616452 by the name RepSox, so it does not verify that alias. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Maherali, N., & Hochedlinger, K.
Affiliations
Harvard University (US)
Corresponding author
Hochedlinger, Konrad
Venue
Current Biology
Publisher
Elsevier BV
Published
2009-11
Volume
19
Issue
20
Pages
1718-1723
ISSN
0960-9822 (ISSN-L)
OpenAlex
W2030299771
Cited by
348
References
24
Citations by year
2026: 6 · 2025: 4 · 2024: 7 · 2023: 10 · 2022: 6 · 2021: 14 · 2020: 9 · 2019: 15 · 2018: 18 · 2017: 12 · 2016: 26 · 2015: 30 · 2014: 40 · 2013: 29 · 2012: 36
FWCI
16.36
Type
journal article
Language
en
Open access
Locations
  • Current Biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (1dp2od003266-01)
  • Natural Sciences and Engineering Research Council of Canada
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD058013)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
induced pluripotent stem cells, TGF-beta signaling, TGF-β receptor inhibition, cellular reprogramming, SOX2, c-Myc, Oct4, KLF4, fibroblast reprogramming, reprogramming efficiency
MeSH terms
Receptor, Transforming Growth Factor-beta Type I, Kruppel-Like Factor 4, Animals, Cell Differentiation, Cell Line, Signal Transduction, Transforming Growth Factor beta, Proto-Oncogene Proteins c-myc, Protein Serine-Threonine Kinases, Receptors, Transforming Growth Factor beta, Cell Culture Techniques, Protein Kinase Inhibitors, Mice, SOXB1 Transcription Factors, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review